Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review

Published:2017-04-20 Issue: Volume:8 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Leere Julius Simoni,Karmisholt Jesper,Robaczyk Maciej,Vestergaard Peter

Funder

Aalborg Universitet

Aalborg Universitetshospital

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference81 articles.

1. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop;Bilezikian;J Clin Endocrinol Metab,2014

2. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients;Christiansen;Bone,1997

3. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease;Valdemarsson;J Intern Med,1998

4. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years;Rubin;J Clin Endocrinol Metab,2008

5. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery;Silverberg;N Engl J Med,1999

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational drug repurposing for primary hyperparathyroidism;Molecular and Cellular Endocrinology;2024-04

2. Parathyroid Gland and Bone Therapies;Endocrinology;2023-12-15

3. Zoledronik asit infüzyonu sonrası COVİD-19’u taklit eden akut faz reaksiyonu;Ege Tıp Dergisi;2023-09-18

4. Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiency;Endocrine;2023-05-03

5. Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis;Frontiers in Endocrinology;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3